US Stocks
/
Atea Pharmaceuticals, Inc. Share Price
Atea Pharmaceuticals, Inc. Share Price

Atea Pharmaceuticals, Inc. Share Price

NASDAQ: AVIR | Small Cap
$5.15
-$0.01 (-0.29%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Atea Pharmaceuticals, Inc. Stock Performance

Open
$5.15
Prev. Close
$5.17
Circuit Range
N/A
Day Range
$5.11 - $5.23
Year Range
$2.92 - $6.43
Volume
23,290
Average Traded
$5.14

Atea Pharmaceuticals, Inc. Share Price Today

As of 11 October 2026, Atea Pharmaceuticals, Inc.'s share price is $5.15. The stock opened at $5.15, compared to its previous close of $5.17. During today's trading session, Atea Pharmaceuticals, Inc.'s share price traded between $5.11 and $5.23, with an average price of $5.17. Over the past 52 weeks, the stock has recorded a high of $6.43 and a low of $2.92. In terms of performance, Atea Pharmaceuticals, Inc.'s share price has declined by 6.62% over the last six months and is up 58.95% on a year-on-year basis.

Atea Pharmaceuticals, Inc. Share Price Chart

$5.11$5.23
L
Show Current Price
H

Atea Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$419.70M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.06
Revenue (TTM)
$0.00
Return On Equity (TTM)
-80.96%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
21.69%

Atea Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.05-$44.87-$45.44-$32.93
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-6.71%-1.27%27.53%

Atea Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$115.91-$135.96-$168.39-$158.35
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-17.30%-23.85%5.96%

About Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Atea Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$5.11
$5.14
-1.34%
Sep 2026
$5.38
$5.21
-4.40%
Aug 2026
$4.70
$5.45
+16.08%
Jul 2026
$4.69
$4.70
+0.97%
Jun 2026
$4.55
$4.65
-0.11%
May 2026
$5.41
$4.66
-15.59%
Apr 2026
$5.43
$5.51
+2.60%
Mar 2026
$4.71
$5.38
+14.61%
Feb 2026
$4.18
$4.69
+10.61%
Jan 2026
$3.52
$4.24
+18.27%
Dec 2025
$3.05
$3.58
+16.02%
Nov 2025
$3.21
$3.09
-4.63%

AVIR Share Price FAQs

What is Atea Pharmaceuticals, Inc. share price today?

chevron-up
Atea Pharmaceuticals, Inc. share price today is $5.15 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Atea Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Atea Pharmaceuticals, Inc. stock is $6.43, while the 52 week low is $2.92 as of 10 Oct '26.

What is AVIR's market capitalisation today?

chevron-up
AVIR market capitalisation is $419.70M as of October 11, 2026, at 2:06 am IST.

What is AVIR's net income for the last quarter?

chevron-up
AVIR's net income for the last quarter is -32.93B USD.

What is the 5 year returns of AVIR?

chevron-up
The 5 year returns of AVIR is -55.76% as on 10 Oct '26.

What is the high & low stock price of AVIR today?

chevron-up
AVIR stock price hit a high of $5.23 and low of $5.11 as of 10 Oct '26.

Can I buy AVIR shares in India?

chevron-up
Yes. You can buy AVIR in India by opening an international trading account.